Articles published by Silo Pharma, Inc.
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
April 10, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
February 28, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
February 01, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
January 24, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
January 04, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
December 28, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
November 08, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
September 12, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Participation on Webull Corporate Communications Service Platform
June 02, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders
April 19, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia
March 15, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
February 13, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Expansion of Intellectual Property Portfolio
February 02, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Silo Pharma Announces Stock Repurchase Program
January 31, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.